Skip to main content

Want a detailed portfolio tracker?

Adaptive Biotechnologies (ADPT) Total Debt (2016 - 2026)

Adaptive Biotechnologies (ADPT) total debt from Dec 31, 2016 to Mar 31, 2026. The current Adaptive Biotechnologies (ADPT) total debt is $282M. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Total Debt

Total Debt

Adaptive Biotechnologies (ADPT) Total Debt CAGR table

PeriodCAGR
1 Year TTM-12.20%
3 Years TTM-6.71%
5 Years TTM-2.99%

Annual Total Debt change of Adaptive Biotechnologies (ADPT)

YearTotal DebtChange
2025$288M
-14.59%
2024$337M
-4.53%
2023$353M
-10.10%
2022$393M
+22.95%
2021$319M
-14.45%
2020$373M
+9.34%
2019$341M
+1039.81%
2018$30M
N/A
2017$0
N/A
2016$0
N/A

Comparison Adaptive Biotechnologies (ADPT) total debt with competitors

Adaptive Biotechnologies (ADPT) total debt is $281.70M.

TickerNameTotal DebtUpside
ADVBAdvanced Biomed Inc$1.44M-99.49%
NDRAENDRA Life Sciences Inc$1.65M-99.41%
MBAICheckCap Ltd$1.83M-99.35%
CHEKCheck-Cap Ltd$1.83M-99.35%
APDNApplied Dna Sciences Inc$2.95M-98.95%
MYNZMainz Biomed N.V.$3.13M-98.89%
BIAFBioAffinity Technologies Inc$4.28M-98.48%
ISPCiSpecimen Inc$6.44M-97.71%
PRPOPrecipio Inc$6.64M-97.64%
XWELXWELL Inc$14.91M-94.71%
XGNExagen Inc$37.52M-86.68%
IMDXInsight Molecular Diagnostics Inc$51.12M-81.85%
FONRFonar Corp$54.77M-80.56%
PRPHProPhase Labs Inc$58.84M-79.11%
PSNLPersonalis Inc$70.63M-74.93%
BDSXBiodesix Inc$85.50M-69.65%
CSTLCastle Biosciences Inc$86.39M-69.33%
VCYTVeracyte Inc$91.99M-67.34%
CDNACaredx Inc$97.53M-65.38%
FLGTFulgent Genetics Inc$112.22M-60.17%
MDXHMDxHealth SA$160.05M-43.19%
BLLNBilliontoone Inc - Class A$195.11M-30.74%
TWSTTwist Bioscience Corp$221.12M-21.51%
WGSGeneDx Holdings Corp - Class A$252.18M-10.48%
GRALGRAIL Inc$302.79M+7.49%
BNRBurning Rock Biotech Ltd$304.48M+8.09%
MYGNMyriad Genetics Inc$336.30M+19.38%
NEONeogenomics Inc$523.27M+85.75%
NOTVInotiv, Inc. Common Stock$625.32M+121.98%
OPKOpko Health Inc$652.19M+131.52%
NTRANatera Inc$840.38M+198.32%
MEDPMedpace Holdings Inc$1.53B+443.59%
IDXXIdexx Laboratories Inc$1.83B+549.41%
GHGuardant Health Inc$2.10B+644.18%
RDNTRadnet Inc$2.53B+799.07%
SHCSotera Health Company$2.61B+827.72%
EXASExact Sciences Corp$3.46B+1128.11%
MTDMettler-Toledo International Inc$3.71B+1217.29%
CRLCharles River Laboratories International Inc$4.74B+1583.35%
RVTYRevvity Inc$4.81B+1608.86%
AAgilent Technologies Inc$5.94B+2009.69%
ICLRIcon Plc$7.08B+2412.03%
WATWaters Corp$9.24B+3179.73%
LHLaboratory Corp Of America Holdings$10.34B+3571.14%
IQVIQVIA Holdings Inc$23.33B+8180.44%